Skip to main content

Cytotoxic Necrotizing Factor Is an Effective Immunogen in a Yersinia pseudotuberculosis Aerosol Mouse Model

  • Conference paper
  • First Online:

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 954))

Abstract

There appears to be a link between bacteria producing certain Rho-activating toxins and respiratory disease. This class of toxins includes the cytotoxic necrotizing factor (CNF) of Escherichia coli, the dermonecrotic toxin (DNT) of certain Bordetella sp., and the CNF homologue of Yersinia pseudotuberculosis (CNFY). The host targets for these toxins are the GTP-binding proteins of the Rho family that function in a number of signaling pathways, including the modification of actin regulators. The toxins’ effect on Rho activity is a result of deamidation of the Rho proteins, leading to constitutive activation of Rho GTPases that are key regulators of the actin cytoskeleton. Because the cytoskeleton is involved in migration of phagocytes, phagocytosis, and the secretion of cytokines, this permanent activation of Rho proteins impairs host immune responses. Necrotoxic (CNF+) E. coli strains are associated with necrotizing pneumonia. Another member of this toxin family, DNT, is essential for virulence in a porcine pneumonia model (Bordetella bronchiseptica) and appears to be responsible for the severe lung damage in laboratory mice infected with this pathogen. The CNFY homologue is present in all strains of Y. pseudotuberculosis and Y. pestis that have been examined to date, although Y. pestis and many strains of Y. pseudotuberculosis do not produce the toxin due to a truncation in the cnf locus. We found that a Y. pseudotuberculosis strain expressing CNFY was virulent in the aerosol mouse model, while the CNF-negative isogenic strain did not cause mortality even at 100 LD50. We expressed CNFY in E. coli and vaccinated mice with the purified toxoided protein. Vaccinated animals were protected from >600 aerosol LD50 of a virulent CNFY+ strain but were not protected from a virulent strain carrying the truncated toxin gene. Thus, although CNFY is not required for aerosol virulence of all Y. pseudotuberculosis strains, it is an effective immunogen for CNFY+ strains. The Rho-activating toxin family may be an attractive target for development of medical countermeasures for necrotizing pneumonias.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Anderson GW, Leary SEC, Williamson ED et al ( 1996) Recombinant V antigen protects mice against pneumonic and bubonic plague caused by FI capsule postive and negative strains of Yersinia pestis. Infect Immun 64:4580–4585

    Article  PubMed  CAS  Google Scholar 

  • Breitschwerdt EB, DebRoy C, Mexas AM et al (2001) Isolation of necrotoxigenic Escherichia coli from a dog with hemorrhagic pneumonia. J Am Vet Med Assoc 226:2016–2019

    Article  Google Scholar 

  • Brockmeier SL, Register KB, Magyar T et al (2002) Role of the dermonecrotic toxin of Bordetella bronchiseptica in the pathogenesis of respiratory disease in swine. Infect Immun 70:481–490

    Article  PubMed  CAS  Google Scholar 

  • Guyton AC (1947) Measurement of the respiratory volumes of laboratory animals. Am J Physiol 150:70–77

    Article  PubMed  CAS  Google Scholar 

  • Lemonnier M, Landraud L, Lemichez E (2007) Rho GTPase-activating bacterial toxins: from bacterial virulence regulation to eukaryotic cell biology. FEMS Microbiol Rev 31:515–534

    Article  PubMed  CAS  Google Scholar 

  • Lockman HA, Gillespie RA, Baker BD et al (2002) Yersinia pseudotuberculosis produces a cytotoxic necrotizing factor. Infect Immun 70:2708–2714

    Article  PubMed  CAS  Google Scholar 

  • Munro P, Lemichez E (2005) Bacterial toxins activating Rho GTPases. Curr Top Microbiol Immunol 291: 177–190

    Article  PubMed  CAS  Google Scholar 

  • Munro P, Flatau G, Anjure F et al (2005) The Rho GTPase activators CNF1 and DNT bacterial toxins have mucosal adjuvant properties. Vaccine 23:2551–2556

    Article  PubMed  CAS  Google Scholar 

  • Worsham PL, Roy CJ, Hunter M et al (2005) Comparative pathogenesis of Yersinia pestis, Y. pseudotuberculosis, and transitional strains. Department of Homeland Security S&T R&D Partnering Conference, 26–28 April 2005

    Google Scholar 

  • Worsham PL, Mou S, Cote C et al (2008) Cytotoxic necrotizing factor (CNF) contributes to virulence of Yersinia pseudotuberculosis strain YpIII in a murine pneumonia model. American Society for Microbiology, General Meeting, Boston, MA, June 2008

    Google Scholar 

Download references

Acknowledgments

This research was sponsored by the Defense Threat Reduction Agency JSTO-CBD project number 1.1A0020_07_RD_B. The views expressed in this publication are those of the author(s) and do not reflect the official policy of the Department of the Army, Department of Defense or the US Government.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Patricia L. Worsham .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media New York

About this paper

Cite this paper

Mou, S., Cote, C.K., Worsham, P.L. (2012). Cytotoxic Necrotizing Factor Is an Effective Immunogen in a Yersinia pseudotuberculosis Aerosol Mouse Model. In: de Almeida, A., Leal, N. (eds) Advances in Yersinia Research. Advances in Experimental Medicine and Biology, vol 954. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3561-7_23

Download citation

Publish with us

Policies and ethics